Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0042109 (
urticaria
)
6,569
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Some etiologic possibilities which must be considered are foods, drugs, infection, inhalant sensitivity, psychic factors, physical agents, underlying
connective tissue disease
or neoplasm, insect bite or stings and genetic abnormalities. A painstaking history and a complete physical examination are, of course, mandatory. These are followed by appropriate studies for whatever etiologic factors are suggested by the history and physical examination. Certain routine or more sophisticated studies might be indicated including a complete blood count, urinalysis, stools for ova and parasites, antinuclear antibody titer, complete complement, sedimentation rate, sinus, chest and dental X rays and any other specified test depending on where the clues lead. O'Loughlin described a practical approach in the use of laboratory studies for the diagnosis of chronic urticaria. Skin tests can be helpful especially for inhalants, but food tests are usually not reliable in the diagnosis of chronic urticaria. The acute
urticaria
reaction to a food is clinically obvious and this type of patient does not usually seek medical attention or need extensive investigation. Treatment includes a few basic medications. Hydroxyzine (Atarax, Vistaril), which combines tranquilizer and antihistamine action, is frequently effective. Cyproheptadine HCL (Periactin) both a serotonin and histamine antagonist with anticholinergic effect, is also helpful--especially in combination with hydroxyzine. Antihistamines, ephedrine, epinephrine, aminophyllin and occasionally corticosteroids are helpful. Immunotherapy with inhalants is occasionally indicated. Eliminating possible offending foods, dyes or drugs has been previously discussed. Anti-candidal therapy and low yeast diet is effective when indicated. The final aspect of the investigation and treatment process might best be described as "patient support"--patience on the part of the physician. It should be realized that in 75% of the cases of chronic urticaria, no convincing etiology is found. It should also be realized that
urticaria
all too frequently "settles down" due as much to the natural course as to the careful ministrations of the physician.
...
PMID:An allergist looks at urticaria. 13 66
Urticaria
is a very common disease which is often associated with angioedema. Release of histamine and perhaps other mediators from the cutaneous mast cells is believed to be the likeliest cause for the development of these wheals in most instances, but there may be both non-immunological as well as immunological inputs into this final common pathway. The former include trauma, cholinergic mechanisms and non-immunological histamine release by drugs. Immune mechanisms most commonly are of the IgE-mediated type, but occasionally the activation of complement or other mediators of hypersensitivity may be involved. Drug and food allergy are among the most common causes of acute
urticaria
, but there are numerous other possibilities which mandate a thorough general medical history and physical examination (including ruling out infection,
connective tissue disease
and neoplasms). In cases of chronic urticaria, when the lesions have persisted for longer than about 2 months, no cause for the disease is discernable in most instances. However, in these cases, as well as in acute
urticaria
, symptomatic treatment generally can provide substantial symptom relief, with emphasis on the astute use of various types of antihistamines.
...
PMID:The urticarias. Current concepts in pathogenesis and treatment. 286 46
Urticarial vasculitis, a form of leukocytoclastic vasculitis involving the postcapillary venules, is classified as a type III hypersensitivity reaction and has been associated with
connective tissue disease
. The lesions resemble
urticaria
and typically persist for more than 24 hours. Urticarial vasculitis usually affects young women, and the diagnosis is confirmed at histologic examination. Patients with urticarial vasculitis can be divided into 2 types--those with normal complement levels and those with hypocomplementemic urticarial vasculitis (HUV). Patients with normocomplementemic urticarial vasculitis have a milder course than do patients with HUV, a condition that has a strong association with systemic lupus erythematosus. Angioedema, ocular inflammation, obstructive lung disease, and glomerulonephritis are commonly associated with HUV. We describe the case of a girl with systemic lupus erythematosus and HUV who also had pancreatitis, hypothyroidism, and elevated levels of antiphospholipid antibodies.
...
PMID:Hypocomplementemic urticarial vasculitis: report of a 12-year-old girl with systemic lupus erythematosus. 1239 49
Angioedema without an associated urticarial syndrome evokes a completely different differential diagnosis from
urticaria
. This review of the literature discusses hereditary angioedema as prototype of angioedema without
urticaria
. The review then establishes a differential diagnosis for angioedema, which includes allergic contact dermatitis,
connective tissue disease
, endocrine associations, parasitic disease, tumor masses, and miscellaneous causes for angioedema. Angioedema without
urticaria
is a distinct syndrome differing from chronic urticaria. The astute clinician should be familiar with the spectrum of disorders ranging from a functional or quantitative deficiency in C1-esterase inhibitor to a panoply of cutaneous and internal medical disorders. Angioedema without
urticaria
is a symptom in which there are many different disease mechanisms producing subcutaneous swelling recognizable as angioedema.
...
PMID:Differential diagnosis of angioedema. 1247 44
Chronic urticaria is a common disorder which can be extremely distressing and disabling for the patients. Anamnesis and clinical investigations are very helpful for the diagnosis. Bacterial, viral or parasitic infections can be associated with chronic urticaria, although the mechanisms which may link infectious diseases and chronic urticaria remain unclear. Recently, direct relationship between chronic urticaria and Helicobacter pylori, hepatitis C virus and Toxocara canis infections have been postulated. Numerous studies have also shown that chronic urticaria and angiodema are significantly associated with thyroid autoimmunity. A
connective tissue disorder
should be investigated if skin biopsy shows histologic evidences of vasculitis or if the patient has signs of systemic disease. Despite extensive laboratory investigations, 60 to 80% of chronic urticaria remain idiopathic. Large clinical studies have shown that extensive screening is unnecessary. Second-generation, low-sedation H1-antihistamines are the treatment of choice in chronic idiopathic
urticaria
. Combined therapies with first and second-generation H1-antihistamines or with H1 and H2-antihistamines have been proposed and found to be effective. Systemic corticoids and immunosuppressive agents should be reserved for patients with severe and disabling chronic urticaria but they cause undesirable effects and toxicity.
...
PMID:[Chronic urticaria: what problems for the physicians?]. 1284 3
Cutis laxa (CL) is an inherited or acquired
connective tissue disorder
characterized clinically by loosely hanging skin folds. There is often preceding cutaneous inflammatory eruption (ie,
urticaria
, eczema, erythema multiforme), and there is frequently internal organ involvement of the gastrointestinal, urogenital, pulmonary, and cardiovascular systems. Histologically, there are degenerative changes in the dermal elastic fibers. Of the few reports on this rare disorder, authors have speculated about an immune-mediated destruction of elastic fibers, and monoclonal gammopathies, such as multiple myeloma or heavy chain deposition disease, have a recognized association with CL. We report an unusual case of rapidly progressing acquired CL associated with leukocytoclastic vasculitis, IgA myeloma, and an immune complex-mediated glomerulonephritis. Light microscopy of the lax skin revealed complete absence of elastic fibers in areas of vasculitis.
...
PMID:Acquired cutis laxa following urticarial vasculitis associated with IgA myeloma. 1946 78
A 41-year-old Hispanic woman with a 20 pack-year smoking history presented with worsening shortness of breath on exertion that gradually started 2 years ago, then significantly deteriorated over the last 4 months. She was diagnosed with COPD 2 months prior to her presentation and started on treatment with fluticasone propionate and albuterol. Her medical history was relevant for undifferentiated
connective tissue disorder
diagnosed 5 years prior due to a positive antinuclear antibody test, arthralgia, recurrent urticarial skin rash, peripheral neuropathy, abdominal pain, and diffuse body swelling. She was started on treatment with prednisone and azathioprine at the time and had substantial improvement in the occurrence of her
urticaria
. She also had a history of recurrent laryngeal edema of unclear etiology. She had no history of IV drug abuse, no exposure to animals, was not sexually active, and had no recent travel outside of Florida. There was no significant family history of lung diseases.
...
PMID:A 41-year-old woman with shortness of breath and history of rash and recurrent laryngeal edema. 2564 15
Urticarial vasculitis is an eruption of erythematous wheals that clinically resemble
urticaria
but histologically show changes of leukocytoklastic vasculitis. In association with
connective tissue disease
it is most commonly seen complicating Systemic lupus erythematous (SLE) and, less often, Sjogren's syndrome. Here, we report a 25-year-old woman who developed SLE in 1998. In May 2013 she presented with urticarial vasculitis; her skin biopsy was consistent with leukocytoclastic vasculitis. She also developed bilateral uveitis. She had most of the clinical and laboratory characteristics of hypocomplementic urticarial vasculitis syndrome (HUVS) which is difficult to be differentiated from SLE. She was treated with high-dose prednisone, Mycophenolate Mofetil (MMF), colchicine, and Dapsone but failed. We decided to give her Rituximab (RTX), her urticarial vasculitis and uveitis symptoms improved significantly. Unfortunately, later on she presented with severe discoid lupus. We started her on thalidomide and responded well. Our case highlights that Rituximab is a good option for severe refractory urticarial vasculitis and thalidomide is effective in treatment of discoid lupus erythematosus (DLE), and can be used safely in specialist rheumatological practice.
...
PMID:Successful Treatment of Urticarial Vasculitis in a Patient With Systemic Lupus Erythematosus With Rituximab. 3319 8